$CLSH
CLS Holdings USA, Inc. Stock $clsh

$clsh Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000118518524000858 Filed on August 29, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$4.805M	$4.723M	$19.96M
YoY Change	-6.05%	-15.32%	-13.71%
Cost Of Revenue	$2.757M	$2.776M	$11.44M
YoY Change	-2.95%	-42.61%	-14.17%
Gross Profit	$2.048M	$1.947M	$8.520M
YoY Change	-9.92%	162.9%	-13.1%
Gross Profit Margin	42.63%	41.23%	42.68%
Selling, General & Admin	$2.185M	$2.614M	$10.52M
YoY Change	-19.97%	69.93%	-5.32%
% of Gross Profit	106.67%	134.26%	123.44%
Research & Development	$140.00		$4.195K
YoY Change	-90.44%		418.54%
% of Gross Profit	0.01%		0.05%
Depreciation & Amortization	$134.5K	$332.4K	$830.5K
YoY Change	-19.21%	40.83%	-12.77%
% of Gross Profit	6.57%	17.07%	9.75%
Operating Expenses	$2.185M	$2.614M	$10.52M
YoY Change	-19.97%	69.93%	-22.47%
Operating Profit	-$136.6K	-$667.2K	-$1.997M
YoY Change	-70.05%	-16.38%	-46.9%
Interest Expense	-$159.4K	-$781.6K	-$1.898M
YoY Change	-134.84%	21.26%	-171.16%
% of Operating Profit
Other Income/Expense, Net	-$159.4K		-$341.1K
YoY Change	-133.79%		-96.15%
Pretax Income	-$296.0K	$2.415M	-$2.338M
YoY Change	-1974.28%	-166.93%	-81.48%
Income Tax	$524.9K	$767.2K	$2.147M
% Of Pretax Income		31.77%
Net Earnings	-$820.9K	$1.648M	-$4.488M
YoY Change	76.97%	-146.6%	-67.48%
Net Earnings / Revenue	-17.08%	34.89%	-22.48%
Basic Earnings Per Share	-$0.01		-$0.05
Diluted Earnings Per Share	-$0.01	$0.01	-$0.05
COMMON SHARES
Basic Shares Outstanding	124.5M shares	137.7M shares	98.86M shares
Diluted Shares Outstanding	125.1M shares		98.86M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$521.4K	$600.0K	$600.0K
YoY Change	-49.61%	-39.9%	-39.9%
Cash & Equivalents	$521.3K	$600.0K	$600.0K
Short-Term Investments
Other Short-Term Assets	$2.639M	$49.31K	$49.31K
YoY Change	2008.77%	-66.67%	-66.67%
Inventory	$2.038M	$1.969M	$1.969M
Prepaid Expenses	$10.00K	$49.31K
Receivables	$1.214M	$682.9K	$682.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.412M	$3.301M	$3.301M
YoY Change	29.04%	-28.11%	-28.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.290M	$2.424M	$3.899M
YoY Change	-17.48%	-16.8%	-14.4%
Goodwill	$557.9K	$557.9K
YoY Change	0.0%	0.0%
Intangibles	$9.152K	$9.978K
YoY Change	-95.45%	-95.23%
Long-Term Investments
YoY Change
Other Assets	$157.5K	$157.5K	$157.5K
YoY Change	-26.97%	0.0%	0.0%
Total Long-Term Assets	$4.507M	$4.624M	$4.624M
YoY Change	-15.0%	-15.6%	-15.6%
TOTAL ASSETS
Total Short-Term Assets	$6.412M	$3.301M	$3.301M
Total Long-Term Assets	$4.507M	$4.624M	$4.624M
Total Assets	$10.92M	$7.925M	$7.925M
YoY Change	6.31%	-21.31%	-21.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.553M	$2.509M	$2.509M
YoY Change	39.04%	39.87%	39.87%
Accrued Expenses	$1.199M	$1.294M	$1.294M
YoY Change	-39.46%	-33.4%	-33.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$2.020M	$1.526M	$1.526M
YoY Change	-63.92%	-71.63%	-71.63%
Total Short-Term Liabilities	$16.20M	$14.23M	$14.23M
YoY Change	-7.14%	-12.92%	-12.92%
LONG-TERM LIABILITIES
Long-Term Debt	$4.915M	$5.286M	$5.286M
YoY Change	-13.23%	-11.7%	-11.7%
Other Long-Term Liabilities	$1.308M	$1.319M	$1.319M
YoY Change	-8.27%	-14.61%	-14.61%
Total Long-Term Liabilities	$6.223M	$6.605M	$6.605M
YoY Change	-12.23%	-12.29%	-12.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.20M	$14.23M	$14.23M
Total Long-Term Liabilities	$6.223M	$6.605M	$6.605M
Total Liabilities	$22.42M	$20.83M	$19.69M
YoY Change	-8.61%	-12.72%	-13.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$114.2M	-$113.4M
YoY Change	4.43%	4.12%
Common Stock	$18.14K	$12.45K
YoY Change	149.97%	71.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.36M	-$11.77M	-$11.77M
YoY Change
Total Liabilities & Shareholders Equity	$10.92M	$7.925M	$7.925M
YoY Change	6.31%	-21.31%	-21.31%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	-$820.9K	$1.648M	-$4.488M
YoY Change	76.97%	-146.6%	-67.48%
Depreciation, Depletion And Amortization	$134.5K	$332.4K	$830.5K
YoY Change	-19.21%	40.83%	-12.77%
Cash From Operating Activities	$252.3K	$219.8K	$808.7K
YoY Change	-67.79%	-72.13%	-451.82%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$97.45K	$148.1K
YoY Change	-100.0%	801.48%	-2.73%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$40.00K	$0.00
YoY Change	-100.0%	-671.43%	-100.0%
Cash From Investing Activities	$0.00	-$57.45K	-$148.1K
YoY Change	-100.0%	222.57%	36.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.269M	-261.3K	-$1.059M
YoY Change	-439.62%	-60.43%	-12.86%
NET CHANGE
Cash From Operating Activities	$252.3K	219.8K	$808.7K
Cash From Investing Activities	$0.00	-57.45K	-$148.1K
Cash From Financing Activities	$2.269M	-261.3K	-$1.059M
Net Change In Cash	$2.521M	-98.86K	-$398.4K
YoY Change	6853.7%	-189.38%	-74.35%
FREE CASH FLOW
Cash From Operating Activities	$252.3K	$219.8K	$808.7K
Capital Expenditures	$0.00	$97.45K	$148.1K
Free Cash Flow	$252.3K	$122.4K	$660.6K
YoY Change	-66.92%	-84.27%	-272.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-05-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-55546
CY2024	dei	Entity Registrant Name EntityRegistrantName	CLS HOLDINGS USA, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-1352286
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	516 S. 4th Street
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89101
CY2024	dei	City Area Code CityAreaCode	416
CY2024	dei	Local Phone Number LocalPhoneNumber	922-4539
CY2024	dei	Security12g Title Security12gTitle	Common Stock, par value $.0001
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	2102269	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	124500873	shares
CY2024	dei	Auditor Firm AuditorFirmId	2738
CY2024	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2024	dei	Auditor Location AuditorLocation	The Woodlands, Texas
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600007	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	998421	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	682894	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	431204	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1968573	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	3012932	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	49309	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	148953	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	3300783	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	4591510	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3318550	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2687146	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2423553	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2913077	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1475351	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1641577	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	348015	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	588217	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9978	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	209088	usd
CY2024Q2	us-gaap	Goodwill Goodwill	557896	usd
CY2023Q2	us-gaap	Goodwill Goodwill	557896	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157500	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157500	usd
CY2024Q2	us-gaap	Assets Assets	7925061	usd
CY2023Q2	us-gaap	Assets Assets	10070648	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3356059	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2728572	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	3600	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	634594	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	471380	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	443467	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	374004	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	96224	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	86887	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8899863	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6752457	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14229035	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16340529	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1318644	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1544283	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	100252	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	200280	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	193756	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	902339	usd
CY2024Q2	us-gaap	Liabilities Liabilities	20833859	usd
CY2023Q2	us-gaap	Liabilities Liabilities	23871220	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	345000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	187500000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	124500873	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	124500873	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72543141	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72543141	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	12450	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	7255	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	101519599	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	96147784	usd
CY2024Q2	clsh	Stock Payable StockPayable	65702	usd
CY2023Q2	clsh	Stock Payable StockPayable	65702	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113367050	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108879446	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-11769299	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-12658705	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	-1139499	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	-1141867	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12908798	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13800572	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7925061	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10070648	usd
CY2024	us-gaap	Revenues Revenues	19961133	usd
CY2023	us-gaap	Revenues Revenues	23133607	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	11441406	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	12558959	usd
CY2024	us-gaap	Gross Profit GrossProfit	8519727	usd
CY2023	us-gaap	Gross Profit GrossProfit	10574648	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10516485	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11877938	usd
CY2024	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss	0	usd
CY2023	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss	1590742	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	866288	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	10516485	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	14334968	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-1996758	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3760320	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1897869	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2667004	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2067141	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6659359	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	936664	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2024	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	2682899	usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	2384	usd
CY2024	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-178674	usd
CY2024	clsh	Gain On Settlement Of Accounts Payable GainOnSettlementOfAccountsPayable	4375	usd
CY2023	clsh	Gain On Settlement Of Accounts Payable GainOnSettlementOfAccountsPayable	145106	usd
CY2024	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	146092	usd
CY2024	clsh	Gain On Settlement Of Note Receivable GainOnSettlementOfNoteReceivable	0	usd
CY2023	clsh	Gain On Settlement Of Note Receivable GainOnSettlementOfNoteReceivable	348165	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-341072	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8863290	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2337830	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12623610	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2147406	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2220675	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-4485236	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-14844285	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2368	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1044656	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-4487604	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-13799629	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98862205	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60655460	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98862205	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60655460	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17148982	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	11532680	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	656	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-6659359	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-14844285	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13800572	usd
CY2024	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2174000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	284112	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	38800	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	25756	usd
CY2024	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-592848	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-3447190	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-4485236	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12908798	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-4485236	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-14844285	usd
CY2024	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-178674	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	64556	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2024	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	989807	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	801535	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2067141	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-6659359	usd
CY2024	clsh	Gain On Settlement Of Note Receivable GainOnSettlementOfNoteReceivable	0	usd
CY2023	clsh	Gain On Settlement Of Note Receivable GainOnSettlementOfNoteReceivable	348165	usd
CY2024	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	146092	usd
CY2024	clsh	Fair Value Of Shares Vested By Officers FairValueOfSharesVestedByOfficers	0	usd
CY2023	clsh	Fair Value Of Shares Vested By Officers FairValueOfSharesVestedByOfficers	656	usd
CY2024	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss	0	usd
CY2023	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss	1590742	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	866288	usd
CY2024	clsh	Gain On Settlement Of Accounts Payable GainOnSettlementOfAccountsPayable	4375	usd
CY2023	clsh	Gain On Settlement Of Accounts Payable GainOnSettlementOfAccountsPayable	145106	usd
CY2024	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	2682899	usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	2384	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	830511	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	952133	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	38280	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	43122	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	289970	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-143901	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-99644	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-185916	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1044359	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-404670	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-391125	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-353797	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	631865	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	650483	usd
CY2024	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	347549	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	534680	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2147406	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2220675	usd
CY2024	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1407	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-381075	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-331865	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	808688	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-229859	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	148114	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	152275	usd
CY2024	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	304145	usd
CY2024	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
CY2023	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	348165	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-148114	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108255	usd
CY2024	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2030000	usd
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2542530	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	500000	usd
CY2024	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2524000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2024	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2504058	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1717115	usd
CY2024	us-gaap	Repayments Of Debt RepaymentsOfDebt	481943	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	2356806	usd
CY2024	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	84457	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	75633	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1058988	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1215324	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-398414	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1553438	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	998421	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2551859	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	600007	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	998421	usd
CY2024	us-gaap	Interest Paid InterestPaid	582491	usd
CY2023	us-gaap	Interest Paid InterestPaid	1476946	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	2174000	usd
CY2023	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	11532680	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	0	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4390	usd
CY2024	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	978543	usd
CY2023	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	3283	usd
CY2024	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	284112	usd
CY2023	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	0	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	224899	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	46475	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	12400	usd
CY2024	clsh	Return Of Assets Under Financing Lease ReturnOfAssetsUnderFinancingLease	6234	usd
CY2023	clsh	Return Of Assets Under Financing Lease ReturnOfAssetsUnderFinancingLease	0	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 1</b> –<b> BUSINESS ORGANIZATION AND NATURE OF OPERATIONS</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">CLS Holdings USA, Inc. (the “Company”) was originally incorporated as Adelt Design, Inc. (“Adelt”) on March 31, 2011 to manufacture and market carpet binding art. Production and marketing of carpet binding art never commenced.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On November 12, 2014, CLS Labs acquired 10,000,000 shares, or 55.6%, of the outstanding shares of common stock of Adelt from its founder, Larry Adelt. On that date, Jeffrey Binder, the Chairman, President and Chief Executive Officer of CLS Labs, was appointed Chairman, President and Chief Executive Officer of the Company. On November 20, 2014, Adelt adopted amended and restated articles of incorporation, thereby changing its name to CLS Holdings USA, Inc. Effective December 10, 2014, the Company exchanged shares of the Company’s common stock which were issued to CLS Labs in exchange for the 10,000,000 shares that it owned by virtue of the above-referenced purchase from Larry Adelt.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On April 29, 2015, the Company, CLS Labs and CLS Merger Inc., a Nevada corporation and wholly owned subsidiary of CLS Holdings (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) and completed a merger, whereby CLS Merger Inc. merged with and into CLS Labs, with CLS Labs remaining as the surviving entity (the “Merger”). As a result of the Merger, the Company acquired the business of CLS Labs and abandoned its previous business.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has been issued a U.S. patent with respect to its proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. The Company has not commercialized its patented proprietary process or otherwise earned any revenues from it. The Company is currently exploring the sale of the patent since the product the patent produces is currently illegal in the state of Nevada.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 4, 2017, the Company and Alternative Solutions, entered into a Membership Interest Purchase Agreement (the “Acquisition Agreement”), as amended, for the Company to acquire the Oasis LLCs from Alternative Solutions. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions. The Company received final regulatory approval to own its interest in the Oasis LLCs through Alternative Solutions under the revised structure of the transaction on April 26, 2022.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On October 20, 2021, the Company entered into a management services agreement (the “Quinn River Joint Venture Agreement”) through its 50% owned subsidiary, Kealii Okamalu, LLC (“Kealii Okamalu”), with CSI Health MCD LLC (“CSI”) and a commission established by the authority of the Tribal Council of the Fort McDermitt Paiute and Shoshone Tribe (the “Tribe”). The purpose of the Quinn River Joint Venture Agreement is to establish a business (the “Quinn River Joint Venture”) to grow, cultivate, process and sell cannabis and related products. The Quinn River Joint Venture Agreement had a term of 10 years plus a 10-year renewal term from the date the first cannabis crop produced is harvested and sold. Pursuant to the Quinn River Joint Venture Agreement, Kealii Okamalu leased approximately 5-10 acres of the Tribe’s land located along the Quinn River at a cost of $3,500 per quarter and managed the design, finance and construction of a cannabis cultivation facility on such tribal lands (the “Cultivation Facility”). Kealii Okamalu also managed the ongoing operations of the Cultivation Facility and related business, including, but not limited to, cultivation of cannabis crops, personnel staffing, product packaging, testing, marketing and sales. Packaged products were branded as “Quinn River Farms.” The Company provided 10,000 square feet of warehouse space at its Las Vegas facility and had preferred vendor status including the right to purchase cannabis flower and the business’s cannabis trim at favorable prices. Kealii Okamalu was required to contribute $6 million towards the construction of the Cultivation Facility and the working capital for the Quinn River Joint Venture. This amount was to be repaid from a portion of the net income of the Quinn River Joint Venture otherwise payable to CSI and the Tribe at the rate of $750,000 per quarter for eight quarters. Kealii Okamalu was to receive one-third of the net profits of the Quinn River Joint Venture.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During the year ended May 31, 2023, the Company evaluated the joint venture with Kealii Okamalu, in light of its partner’s failure to make its required capital contributions. Due to the breach by its partner and the decision, therefore, by the Tribal Council to terminate the Quinn River Joint Venture Agreement, the Company believes it is in its best interest to impair the assets of Kealii Okamalu. This resulted in an impairment charge of $1,590,742 which was charged to operations during the year ended May 31, 2023.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company wound down the operation of Kealii Okamalu during the year ended May 31, 2023 and there were no active operations during the year ended May 31, 2024 and there is no intention to continue doing business under the terms of the Quinn River Joint Venture Agreement or with The Tribe.</p>
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113367050	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Reclassification</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Certain reclassifications, not affecting previously reported net income or cash flows, have been made to the previously issued financial statements to conform to the current period presentation.</p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600007	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	998421	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	38280	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	43122	usd
CY2023Q2	us-gaap	Goodwill Goodwill	557896	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2368	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1044656	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Concentrations of Credit Risk</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company maintains its cash in bank deposit accounts and other accounts, the balances of which at times may be uninsured or exceed federally insured limits. From time to time, some of the Company’s funds are also held by escrow agents; these funds may not be federally insured. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts.</p>
CY2024	us-gaap	Advertising Expense AdvertisingExpense	516528	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	613410	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4195	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	809	usd
CY2024	us-gaap	Revenues Revenues	19961133	usd
CY2023	us-gaap	Revenues Revenues	23133607	usd
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86949369	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	82135826	shares
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	936664	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-112139	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1590742	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	682894	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	431204	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	38280	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	43122	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	386803	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	399728	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1581770	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2613204	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	1968573	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	3012932	usd
CY2024Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	49309	usd
CY2023Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	147953	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	0	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	1000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49309	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	148953	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3318550	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2687146	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2423553	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2913077	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	148114	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	152275	usd
CY2024	clsh	Return Of Assets Under Financing Lease ReturnOfAssetsUnderFinancingLease	6234	usd
CY2024	us-gaap	Depreciation Depreciation	631404	usd
CY2023	us-gaap	Depreciation Depreciation	837224	usd
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	381075	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	331875	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	391125	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	353797	usd
CY2019Q2	clsh	Operating Lease Rightof Use Asset Before Accumulated Amortization OperatingLeaseRightofUseAssetBeforeAccumulatedAmortization	4384520	usd
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4341120	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	28511	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14889	usd
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P9Y
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	221469	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	205888	usd
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4384520	usd
CY2024	clsh	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	2703281	usd
CY2024	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-205888	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1475351	usd
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4341120	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2579009	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1762111	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1762111	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	443467	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1318644	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	624498	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	515754	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	288953	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	299864	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	260243	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	276625	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2265937	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	503826	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1762111	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	357993	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	348015	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9978	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1663593	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	588217	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	866288	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	209088	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	199110	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	114909	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3304	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3304	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3304	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	66	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9978	usd
CY2024Q2	us-gaap	Goodwill Goodwill	557896	usd
CY2023Q2	us-gaap	Goodwill Goodwill	557896	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	157500	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	157500	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157500	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157500	usd
CY2024Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2508769	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1793585	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	313296	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	311505	usd
CY2024Q2	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	533994	usd
CY2023Q2	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	623482	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3356059	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2728572	usd
CY2024	clsh	Gain On Settlement Of Accounts Payable GainOnSettlementOfAccountsPayable	4375	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8437	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18563	usd
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4001431	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	7506102	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1429822	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1416335	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1144127	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2819222	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	6809506	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	196476	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	287167	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	96224	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	86887	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	100252	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	200280	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	196476	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	287167	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	100252	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	96224	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	196476	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	187500000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	345000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	124500873	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72543141	shares
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-4
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	290070272	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72517570	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	217552702	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	574	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1250000	usd
CY2024Q1	clsh	Shares Return SharesReturn	13174402	shares
CY2024Q1	clsh	Class Of Warrant Or Rights Cancelled Expired ClassOfWarrantOrRightsCancelledExpired	454548	shares
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.045
CY2024	clsh	Common Stock Returned Shares Value CommonStockReturnedSharesValue	1318	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	591350	usd
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	12051397	shares
CY2022Q3	clsh	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	6025700	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.4
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	12500	shares
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	656	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	18846721	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.2
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.4
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	3400652	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6801298	shares
CY2022Q3	clsh	Warrant Description WarrantDescription	each warrant issuable pursuant to the conversion of such debentures is exercisable for one share of the Company’s common stock at a price of $0.40 per share
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20726901	shares
CY2024	clsh	Warrants Outstanding Weighted Average Remaining Contractual Term WarrantsOutstandingWeightedAverageRemainingContractualTerm	P1Y3M18D
CY2024Q2	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding	0.43
CY2024	clsh	Class Of Warrant Or Rights Exercisable ClassOfWarrantOrRightsExercisable	20726901	shares
CY2024	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Exercisable ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable	0.43
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1729924	shares
CY2022Q2	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding	1.98
CY2023	clsh	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	20232775	shares
CY2023	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsGranted	0.4
CY2023	clsh	Class Of Warrant Or Rights Exercised ClassOfWarrantOrRightsExercised	0	shares
CY2023	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised	0
CY2023	clsh	Class Of Warrant Or Rights Cancelled Expired ClassOfWarrantOrRightsCancelledExpired	-781250	shares
CY2023	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Cancelled Expired ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsCancelledExpired	0.6
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21181449	shares
CY2023Q2	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding	0.46
CY2024	clsh	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	0	shares
CY2024	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsGranted	0
CY2024	clsh	Class Of Warrant Or Rights Exercised ClassOfWarrantOrRightsExercised	0	shares
CY2024	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised	0
CY2024	clsh	Class Of Warrant Or Rights Cancelled Expired ClassOfWarrantOrRightsCancelledExpired	-454548	shares
CY2024	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Cancelled Expired ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsCancelledExpired	0.41
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20726901	shares
CY2024Q2	clsh	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding	0.43
CY2018Q1	clsh	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	51310	shares
CY2024	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.039
CY2024	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	0.039
CY2024Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	8041667	shares
CY2024	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y7M24D
CY2024Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.039
CY2024Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1187499	shares
CY2024Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.039
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8250000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.039
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	208333	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.039
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8041667	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.039
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.6944	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.038	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10300	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q2	us-gaap	Share Price SharePrice	0.05
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2024	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	60000	usd
CY2024Q2	clsh	Number Of Related Party Notes Payable NumberOfRelatedPartyNotesPayable	7	pure
CY2022Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	12500	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	12500	shares
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	36000	usd
CY2024	us-gaap	Revenues Revenues	19961133	usd
CY2023	us-gaap	Revenues Revenues	23133607	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-9735390	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-12558964	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10225743	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10574643	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2147406	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2220675	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4326509	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3475301	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4326509	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3475301	usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	20602424	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	16549050	usd
CY2022Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	20	acre
CY2023Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	2547	sqft
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	5083	usd
CY2025	us-gaap	Operating Lease Expense OperatingLeaseExpense	5236	usd
CY2026	us-gaap	Operating Lease Expense OperatingLeaseExpense	5393	usd
CY2027	us-gaap	Operating Lease Expense OperatingLeaseExpense	5554	usd
CY2028	us-gaap	Operating Lease Expense OperatingLeaseExpense	5721	usd
	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	10000	usd
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001522222

Files In Submission

Name	View Source	Status
0001185185-24-000858-index-headers.html	Edgar Link	pending
0001185185-24-000858-index.html	Edgar Link	pending
0001185185-24-000858.txt	Edgar Link	pending
0001185185-24-000858-xbrl.zip	Edgar Link	pending
cls20240531_10k.htm	Edgar Link	pending
cls20240531_10kimg001.jpg	Edgar Link	pending
cls20240531_10kimg002.jpg	Edgar Link	pending
clsh-20240531.xsd	Edgar Link	pending
ex_715952.htm	Edgar Link	pending
ex_715953.htm	Edgar Link	pending
ex_715954.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
clsh-20240531_def.xml	Edgar Link	unprocessable
clsh-20240531_cal.xml	Edgar Link	unprocessable
clsh-20240531_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
clsh-20240531_lab.xml	Edgar Link	unprocessable
cls20240531_10k_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLSH
CLS Holdings USA, Inc. Stock $clsh

2024 Q3 Form 10-K Financial Statement

#000118518524000858 Filed on August 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLSH CLS Holdings USA, Inc. Stock $clsh

2024 Q3 Form 10-K Financial Statement

#000118518524000858 Filed on August 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLSH
CLS Holdings USA, Inc. Stock $clsh